The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
- PMID: 17296877
- DOI: 10.1001/archinte.167.3.229
The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
Abstract
Background: Warfarin sodium is a highly efficacious drug, but proper levels of anticoagulation are difficult to maintain. Conflicting data exist on the influence of patient adherence on anticoagulation control.
Methods: We performed a prospective cohort study at 3 anticoagulation clinics to determine the effect of adherence on anticoagulation control. Patients treated with warfarin with a target international normalized ratio of 2.0 to 3.0 were monitored with electronic Medication Event Monitoring System (MEMS) medication bottle caps. Detailed information was collected on other factors that might alter warfarin response.
Results: Among 136 participants observed for a mean of 32 weeks, 92% had at least 1 missed or extra bottle opening; 36% missed more than 20% of their bottle openings; and 4% had more than 10% extra bottle openings. In multivariable analyses, there was a significant association between underadherence and underanticoagulation. For each 10% increase in missed pill bottle openings, there was a 14% increase in the odds of underanticoagulation (P<.001); participants with more than 20% missed bottle openings (1-2 missed days each week) had more than a 2-fold increase in the odds of underanticoagulation (adjusted odds ratio, 2.10; 95% confidence interval, 1.48-2.96). Participants who had extra pill bottle openings on more than 10% of days had a statistically significant increase in overanticoagulation (adjusted odds ratio, 1.73; 95% confidence interval, 1.09-2.74).
Conclusion: Patients have substantial difficulties maintaining adequate adherence with warfarin regimens, and this poor adherence has a significant effect on anticoagulation control.
Similar articles
-
Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.Ann Pharmacother. 2009 Jul;43(7):1165-72. doi: 10.1345/aph.1L707. Epub 2009 Jun 23. Ann Pharmacother. 2009. PMID: 19549747
-
Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.J Heart Valve Dis. 2002 Jul;11(4):583-92; discussion 593. J Heart Valve Dis. 2002. PMID: 12150309 Clinical Trial.
-
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.Thromb Haemost. 2011 Feb;105(2):232-8. doi: 10.1160/TH10-05-0324. Epub 2010 Dec 21. Thromb Haemost. 2011. PMID: 21173999
-
Self-management of anticoagulation.Expert Rev Cardiovasc Ther. 2008 Aug;6(7):979-85. doi: 10.1586/14779072.6.7.979. Expert Rev Cardiovasc Ther. 2008. PMID: 18666848 Review.
-
Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.Pharmacotherapy. 2008 Apr;28(4):540-8. doi: 10.1592/phco.28.4.540. Pharmacotherapy. 2008. PMID: 18363538 Review.
Cited by
-
Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial.J Arrhythm. 2021 Mar 30;37(3):616-625. doi: 10.1002/joa3.12532. eCollection 2021 Jun. J Arrhythm. 2021. PMID: 34141014 Free PMC article.
-
Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment).BMC Health Serv Res. 2019 Aug 1;19(1):539. doi: 10.1186/s12913-019-4372-y. BMC Health Serv Res. 2019. PMID: 31370840 Free PMC article. Clinical Trial.
-
Association between Cerebral Infarction Risk and Medication Adherence in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants.Healthcare (Basel). 2021 Oct 1;9(10):1313. doi: 10.3390/healthcare9101313. Healthcare (Basel). 2021. PMID: 34682992 Free PMC article.
-
Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.Res Pract Thromb Haemost. 2021 Nov 21;5(8):e12614. doi: 10.1002/rth2.12614. eCollection 2021 Dec. Res Pract Thromb Haemost. 2021. PMID: 34849447 Free PMC article.
-
Safety Issues of Herb-Warfarin Interactions.Curr Drug Metab. 2024;25(1):13-27. doi: 10.2174/0113892002290846240228061506. Curr Drug Metab. 2024. PMID: 38465436 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous